We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

33 hedge funds and large institutions have $20.1M invested in Calithera Biosciences, Inc in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

18% less funds holding

Funds holding: 40 → 33 (-7)

26% less capital invested

Capital invested by funds: $27.1M → $20.1M (-$6.97M)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
33
Holders Change
-7
Holders Change %
-17.5%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
14
Reduced
9
Closed
10
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.56M
2
OAM
Oxford Asset Management
United Kingdom
+$155K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$149K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$139K
5
BIT
BlackRock Institutional Trust
California
+$94.6K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.05M
2
First Eagle Investment Management
First Eagle Investment Management
New York
-$312K
3
Renaissance Technologies
Renaissance Technologies
New York
-$300K
4
Millennium Management
Millennium Management
New York
-$283K
5
DTL
Dynamic Technology Lab
Singapore
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$28K -$62 -1 -0.2%
Morgan Stanley
27
Morgan Stanley
New York
$28K +$12.6K +202 +91%
Simplex Trading
28
Simplex Trading
Illinois
$12K -$8.93K -143 -42%
AIM
29
Advantage Investment Management
Iowa
$11K -$6.25K -100 -38%
BA
30
BlackRock Advisors
Delaware
$8K -$2.37K -38 -23%
BIM
31
BlackRock Investment Management
Delaware
$8K – – –
SM
32
Sabby Management
Florida
– -$1.05M -16,225 Closed
Renaissance Technologies
33
Renaissance Technologies
New York
– -$300K -4,622 Closed
DTL
34
Dynamic Technology Lab
Singapore
– -$187K -2,878 Closed
Deutsche Bank
35
Deutsche Bank
Germany
– -$180K -2,771 Closed
FAM
36
Fred Alger Management
New York
– -$81K -1,250 Closed
VKH
37
Virtu KCG Holdings
New York
– -$56K -857 Closed
JP Morgan Chase
38
JP Morgan Chase
New York
– -$23K -354 Closed
AC
39
Amici Capital
New York
– -$21K -318 Closed
Parallax Volatility Advisers
40
Parallax Volatility Advisers
California
– -$13K -200 Closed
TRCT
41
Tower Research Capital (TRC)
New York
– -$6K -85 Closed
1
2

CALA Hedge Fund Activity: Q4 2016 in Review

33 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2016, worth a combined $20.1M — down 26% from $27.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of CALA and 4 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 14 added.

The largest buyer was Adage Capital Partners, adding an estimated $1.56M. The largest seller was Sabby Management, exiting entirely with an estimated $1.05M sold.

  • 33 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2016, down from 40 in Q3 2016.
  • Funds reported $20.1M of Calithera Biosciences, Inc stock for Q4 2016, down 26% quarter-over-quarter.
  • 4 funds opened new Calithera Biosciences, Inc positions in Q4 2016 and 10 closed out, a net change of -6 holders.
  • The largest Calithera Biosciences, Inc buyer in Q4 2016 was Adage Capital Partners, an estimated $1.56M added.
  • The largest Calithera Biosciences, Inc seller in Q4 2016 was Sabby Management, an estimated $1.05M sold.

Based on aggregated 13F filings for Q4 2016.